Aurobindo gets FDA approval for prazosin hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application prazosin hydrochloride capsules USP, 1mg, 2mg and 5mg.